IP Library Granted Patent US 9,522,249
Granted Patent B2
US 9,522,249 · App. 14/107,629 · Granted Dec 20, 2016

Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,522,249
App. No.
14/107,629
Granted
Dec 20, 2016
Kind
B2
Abstract

Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.

Claims (19)

1. An apparatus for converting nitrogen dioxide to nitric oxide suitable for delivery to a human comprising a receptacle including an inlet a cartridge comprising a permeable support comprising vitamin C or Vitamin E, and an outlet, and wherein the inlet is configured to receive a gas flow comprising nitrogen dioxide and fluidly communicate the gas flow through the receptacle to the outlet, such that the gas flow contacts the vitamin inside the receptacle, and the vitamin converts substantially all of the nitrogen dioxide in the gas flow to nitric oxide.

2. The apparatus of claim 1 , wherein the permeable support comprises a substrate that retains water.

3. The apparatus of claim 1 , wherein the permeable support comprises a silica gel.

4. The apparatus of claim 1 , wherein the vitamin includes ascorbic acid, alpha tocopherol or gamma tocopherol.

5. An apparatus for generating a therapeutic gas including nitric oxide comprising:

a permeation cell having liquid nitrogen dioxide and capable of diffusing gaseous nitrogen dioxide into a gas flow; and

a receptacle including an inlet, an outlet and disposed within said receptacle a vitamin C or vitamin E, wherein the inlet is configured to receive the gas flow comprising nitrogen dioxide and fluidly communicate the gas flow through the receptacle to the outlet, such that the gas flow contacts the vitamin inside the receptacle, and the vitamin converts substantially all of the nitrogen dioxide in the gas flow to nitric oxide, thereby generating a therapeutic gas including nitric oxide.

6. The apparatus of claim 5 , wherein the receptacle is a first receptacle, the apparatus further comprising a second receptacle including a second inlet, a second outlet and a second vitamin, wherein the second inlet is configured to receive the gas flow comprising nitrogen dioxide and fluidly communicate the gas flow through the receptacle to the second outlet, such that the gas flow contacts the second vitamin inside the second receptacle, and the second vitamin converts substantially all of the nitrogen dioxide in the gas flow to nitric oxide.

7. The apparatus of claim 6 , wherein the vitamin in the first receptacle and the second vitamin are the same.

8. The apparatus of claim 5 , wherein the receptacle further comprises a permeable support for the vitamin.

9. The apparatus of claim 8 , wherein the permeable support for the vitamin comprises a substrate that retains water.

10. The apparatus of claim 9 , wherein the permeable support for the vitamin comprises a silica gel.

11. The apparatus of claim 6 , wherein the second receptacle further comprises a permeable support for the second vitamin.

12. The apparatus of claim 11 , wherein the permeable support for the vitamin in the first receptacle and the permeable support for the second vitamin are the same.

13. The apparatus of claim 5 , further comprising an air pump capable of generating the gas flow, wherein the permeation cell is configured to receive the gas flow generated by the air pump.

14. The apparatus of claim 13 , wherein the air pump is portable.

15. The apparatus of claim 5 , further comprising an oxygen-enrichment device capable of supplying oxygen in the gas flow, wherein the permeation cell is configured to receive the gas flow enriched by the oxygen-enrichment device.

16. The apparatus of claim 5 , wherein the vitamin comprises ascorbic acid, alpha tocopherol or gamma tocopherol.

17. The apparatus of claim 6 , further comprising a flexible bag operable to inflate and deflate as a mammal receiving the therapeutic gas breathes, and wherein the second receptacle is positioned between the flexible bag and a point at which the therapeutic gas flow including nitric oxide is delivered to the mammal.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2026
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: VERO BIOTECH INC.
Reel/Frame 075308/0198 →
SECURITY INTEREST Recorded Mar 16, 2026
From: VERO BIOTECH INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS COLLATERAL AGENT
Reel/Frame 075117/0935 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 3, 2024
From: RUNWAY GROWTH FINANCE CORP (F/K/A RUNWAY GROWTH CREDIT FUND INC.)
To: VERO BIOTECH INC. (F/K/A VERO BIOTECH LLC)
Reel/Frame 066186/0611 →
SECURITY INTEREST Recorded Jan 3, 2024
From: VERO BIOTECH INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 066187/0865 →
CHANGE OF NAME Recorded Feb 14, 2022
From: VERO BIOTECH LLC
To: VERO BIOTECH INC.
Reel/Frame 059085/0418 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2021
From: ROUNBEHLER, DAVID P.; FINE, DAVID H.
To: CYTERRA CORPORATION
Reel/Frame 057360/0091 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2021
From: CYTERRA CORPORATION
To: GENO LLC
Reel/Frame 057360/0096 →
SECURITY INTEREST Recorded Dec 29, 2020
From: VERO BIOTECH LLC
To: RUNWAY GROWTH CREDIT FUND INC.
Reel/Frame 054866/0589 →
CHANGE OF NAME Recorded Jun 6, 2018
From: GENO LLC
To: VERO BIOTECH LLC
Reel/Frame 046304/0855 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2013
From: ROUNBEHLER, DAVID P.; FINE, DAVID H.
To: GENO LLC
Reel/Frame 031817/0937 →